Discussion of current NHL CAR-T and outlook for allogeneic therapies in DLBCL

Executed on:May 3, 2022 1:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Florida

Board certified medical oncologist with expertise in the study and treatment of lymphoma, NHL, and chronic lymphocytic leukemia (CLL).
Primary research effort emphasizes the development of novel treatment strategies for patients with lymphoma/CLL through the identification of new targets and the utilization of novel targeted therapies.
Has conducted multiple clinical trials and is active in laboratory research with the goal of translating laboratory findings to the clinical setting for the ultimate benefit of the patient.

Interview Goal

Discussion of current autologous DLBCL CAR-T and outlook for allogeneic therapies

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.